Literature DB >> 8449633

Viral hepatitis and drugs: a continuing problem.

A M Patti1, A L Santi, M G Pompa, C Giustini, N Vescia, I Mastroeni, G M Fara.   

Abstract

A seroepidemiological survey of a group of drug abusers has been carried out to determine the prevalence of hepatitis C virus and hepatitis B virus, hepatitis D virus, hepatitis A virus infection markers in sera, as well as to evaluate the role of potential risk factors. A total of 645 symptomless subjects with a history of injecting heroin were recruited as volunteers from methadone maintenance centres in Rome. For all hepatitis viruses the total figures showed high prevalence rates giving considerable viral circulation in this group. Among heroin addicts the prevalence was 63.4% for HCV, 65% for HBV, 13.3% for HDV and 50.9% for HAV. Anti-HCV prevalence correlated with serological evidence of HBV infection. A significant correlation was also found between presence of HCV antibodies and exposure time to drug addiction > 5 years earlier. The data reveal the important role played by needle sharing in the spreading of multiple infections among intravenous drug abusers (IVDA).

Entities:  

Mesh:

Year:  1993        PMID: 8449633     DOI: 10.1093/ije/22.1.135

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan.

Authors:  C J Chang; C H Lin; C T Lee; S J Chang; Y C Ko; H W Liu
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

2.  Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users.

Authors:  I Hernandez-Aguado; J M Ramos-Rincon; M J Aviñio; J Gonzalez-Aracil; S Pérez-Hoyos; M G de la Hera
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis.

Authors:  Erik Seth Kramer; Charlotte Hofmann; Paula G Smith; Mitchell L Shiffman; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

4.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

Authors:  I van Beek; R Dwyer; G J Dore; K Luo; J M Kaldor
Journal:  BMJ       Date:  1998-08-15

5.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

6.  Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users.

Authors:  Mohammad Mehdi Mir-Nasseri; Ashraf Mohammadkhani; Hamid Tavakkoli; Esmaeil Ansari; Hossein Poustchi
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

7.  Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.

Authors:  Meghan D Morris; Stephen Shiboski; Julie Bruneau; Judith A Hahn; Margaret Hellard; Maria Prins; Andrea L Cox; Gregory Dore; Jason Grebely; Arthur Y Kim; Georg M Lauer; Andrew Lloyd; Thomas Rice; Naglaa Shoukry; Lisa Maher; Kimberly Page
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

8.  Seroprevalence of hepatitis B markers among incarcerated intravenous drug users.

Authors:  Zary Nokhodian; Majid Yaran; Peyman Adibi; Nazila Kassaian; Marjan Meshkati; Behrooz Ataei
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.